The results from the current analysis indicate that PD-L1 and PD-L2 may have prognostic value in patients with ES-SCLC and suggest that this is likely not confounded by the demographic or clinicopathologic characteristics assessed in the current analysis. Here, CD274 is linked to small cell lung carcinoma.